About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4868214
Allelic
Composition
Prkacatm1Gsm/Prkaca+
Prkar1atm1.1Lsk/Prkar1a+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkar1atm1.1Lsk mutation (0 available); any Prkar1a mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• mutants do not develop schwannomas or thyroid tumors
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes (J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age (J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma (J:160299)
• 13% of mutants develop osteochondromyoxoma (J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate (J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies (J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts (J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells (J:166728)
• rare development of metastatic osteochondrosarcomas
• rare chondromas in the long bones

skeleton
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes (J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age (J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma (J:160299)
• 13% of mutants develop osteochondromyoxoma (J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate (J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies (J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts (J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells (J:166728)
• rare development of metastatic osteochondrosarcomas
• rare chondromas in the long bones
• overall bone mineralization density is lower than in wild-type mice
• in affected bones, normal cortical bone is replaced by mineralized material
• periosteum of affected bones is abnormal, with occasional cells from lesions crossing the periosteum into the extraosseous space and Sharpey fibers, characteristic of fibrous dysplasia, are observed
• although the bone marrow is expanded by active osteoclastic activity, these cells are not able to mature into osteoblasts and mineralize the matrix resulting in undermineralization
• bones exhibit a lag between bone matrix formation and mineralization and abnormal coordination of these processes with bone resorption

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
CINCA Syndrome DOID:0090029 OMIM:607115
J:166728


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory